MedCap operates mainly in the Nordic life science market. The population of this region is expected to grow by one million every five years until 2040, which will bring an increased need for health and social care. At the same time, the population is ageing. The number of people aged 65 or over has risen by 27 percent since 2002. An ageing population creates additional demand for care services and medical care products. The market is also growing through the development of technology, which brings improved diagnostic techniques and new applications for the treatment of diseases.
MedCap is active in three areas of the life science market: Medical Technology (Medtech) and Specialty Pharma.